Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 1,624 Shares of Cardinal Health, Inc. (NYSE:CAH)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 3.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 51,459 shares of the company’s stock after selling 1,624 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Cardinal Health were worth $6,086,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. State Street Corp boosted its position in shares of Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after purchasing an additional 627,253 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Amundi boosted its position in shares of Cardinal Health by 5.5% in the 4th quarter. Amundi now owns 2,116,291 shares of the company’s stock worth $259,309,000 after purchasing an additional 110,605 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Cardinal Health by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company’s stock worth $179,653,000 after purchasing an additional 44,386 shares during the last quarter. Finally, Two Sigma Advisers LP boosted its position in shares of Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after purchasing an additional 346,362 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

CAH opened at $131.80 on Friday. The business’s 50-day moving average price is $127.35 and its two-hundred day moving average price is $120.04. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $133.67. The company has a market capitalization of $31.84 billion, a price-to-earnings ratio of 24.59, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on CAH shares. Argus set a $148.00 price target on Cardinal Health in a research report on Tuesday, February 4th. Citigroup lifted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.